Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa

Ocular Adnexal Lymphomas are the first cause of primary ocular malignancies, and among them the most common are MALT Ocular Adnexal Lymphomas. Recently systemic immunotherapy with anti-CD20 monoclonal antibody has been investigated as first-line treatment; however, the optimal management for MALT Oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Annibali, Ombretta, Chiodi, Francesca, Sarlo, Chiara, Cortes, Magdalena, Quaranta-Leoni, Francesco M., Quattrocchi, Carlo, Bianchi, Antonella, Bonini, Stefano, Avvisati, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575717/
https://www.ncbi.nlm.nih.gov/pubmed/26425558
http://dx.doi.org/10.1155/2015/895105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575717/
https://www.ncbi.nlm.nih.gov/pubmed/26425558
http://dx.doi.org/10.1155/2015/895105

Ejemplares similares